Cape Town, South Africa
Author's Reply
The genomic tests carried out by Dr. Lastovica et al. indicate that strain NCTC 12408 is Campylobacter concisus. The fact that NCTC 12407, the other strain phenotypically identified as C. mucosalis, was not available because it is nonvital (1) hampers its identification at the genomic level. However, it is highly probable that it is C. concisus too, since biochemical tests that we performed gave the same results obtained with NCTC 12408.
The letter by Dr. Lastovica also suggests that the results of biochemical, tolerance, and susceptibility tests, even if confirmed by a reference center, are of little usefulness with "unusual" campylobacters. I therefore wonder whether genomic assays ought to be carried out also for the most common campylobacter isolates, like C. jejuni and C. coli, which routinely are differentiated by only one test, hippurate hydrolysis.
In any case, researchers who still want to rely on phenotypic criteria for the identification of H2-dependent campylobacters have to bear in mind that susceptibility to cephalothin and production of a dirty yellow pigment are characteristics not of C. mucosalis but of C. concisus strains, as Dr. Lastovica (2) . Since invasive aspergillosis is a lifethreatening disease to immunocompromised patients, fast and VOL. 32, 1994 accurate diagnosis is of vital importance. Antigen detection is very important in this respect. Over the years several methods for the detection of Aspergillus antigens have been published (1, 3, 4) . Haynes ' method uses concentrated urine specimens which are electrophoresed on sodium dodecyl sulfate-polyacrylamide gels and blotted to polyvinyldifluoride paper. The blotted antigens are detected by a detector serum, rabbit serum directed against cell wall antigens from Aspergillus fumigatus. Haynes also published the molecular weights of antigens which he claims to be specific for aspergillosis. Considering that this method seemed very promising for the rapid and accurate detection of Aspergillus antigens and that it is able to detect defined antigens, we introduced it in our laboratory.
Experiments with urine specimens from patients with proven invasive aspergillosis obtained from Haynes showed that our detector serum was able to detect the same antigenic bands on the blots as did Haynes' detector serum. Our detector serum was immune serum directed against cell wall antigens from A. fuimigatus from a conventionally raised New Zealand White rabbit (Haynes did not specify the type of rabbit to be used for immunization). Because we wanted to have negative controls in the test, we investigated 10 urine specimens from healthy individuals and 10 urine specimens from patients without aspergillosis but with urinary tract infections.
In the urine specimens from patients with urinary tract infections, we found strong reactions on the blots in places specific for Aspergillus antigens. From two patients, the causative organism could be isolated; both isolates were Escherichia coli. We preincubated the detector serum from the immunoblot with E. coli that had been treated for 1 h at 100°C. This treatment was intended to remove specific lipopolysaccharide epitopes on the E. coli surface and to improve the exposure of common gram-negative surface antigens (5). When this "absorbed" detector serum was used in the immunoblot test, the previously found reactions in the patients' urine specimens disappeared almost completely.
When investigating urine specimens from patients with urinary tract infections by using unabsorbed sera from conventionally raised rabbits, one should be aware of this pitfall.
E. coli is not the only organism able to cause urinary tract infections, we investigated three Aspergillus detector serum specimens for the presence of antibodies against several other organisms. In all three we found, along with antibodies against E. coli, antibodies against (non-protein A-producing) Staphylococcus saprophyticus, Klebsiella pneumoniae, Enterobacter cloacae, and Proteus mirabilis in varying amounts.
Two of the Aspergillus detector serum specimens were absorbed with E. coli, S. saprophyticus, and K pneumoniae organisms. For this purpose both merthiolate-killed and heattreated (1 h, 100°C) organisms were used. The reactions of the "absorbed" detector sera with water-soluble antigen from A. fumigatus NCPF 2109 on the immunoblot were not affected. On the contrary, the intensity and the number of bands found on blots when "absorbed" detector sera were used in combination with urine specimens from patients with urinary tract infections were lower than when "unabsorbed" detector sera were used.
The use of S. saprophyticus as an absorbing organism had no effect in the reaction between the urine antigens and the treated sera.
After the problems we experienced, we recommend that one check the Aspergillus detector sera before using them in the immunoblot test for the presence of antibodies against common organisms causing urinary tract infections and, if necessary, one incubate the sera before using them with the organisms against which antibodies have been found. (1) . Because of the serious consequences of a positive diagnosis of HIV-1 infection, a report of a reactive HIV-1 EIA should never be made without supplementary, confirmatory testing.
Serial urine samples were collected from 33 neutropenic patients, 10 of whom developed invasive aspergillosis (IA) while undergoing bone marrow transplantation or remission induction therapy for leukemia. Concentrated urine samples from the infected patients were subjected to polyacrylamide gel electrophoresis, blotted, and then incubated with antiserum raised to a cell wall extract of Aspergillusfumigatus (anti-CW) or an immunoglobulin G monoclonal antibody to A. fumigatus galactomannan (EBA1). When IA patient urine blots were probed with anti-CW, major bands at 11 and 18 kilodaltons (kDa); intermediate bands at 13, 14 , and 29 kDa; and minor bands at 38 and 44 kDa were seen. In contrast, EBA1 showed diffuse staining at molecular masses larger than 45 kDa and a single weak band at 21 kDa. Urine samples from the 23 patients with no evidence of IA were unreactive with both anti-CW and EBAL. These antigen bands are likely to represent immunodominant antigens which are excreted during IA and should play a valuable role in the development of rapid diagnostic tests for aspergillosis.
The current high mortality that is associated with invasive aspergillosis (IA) in severely immunocompromised patients (22) is due, in large part, to difficulties in establishing a clinical and/or microbiological diagnosis in the course of infection (17, 33, 34) . A rapid, sensitive, and specific diagnostic test should justify the early administration of antifungal drugs, thereby improving the poor response rates that have been reported (34) . Furthermore, the need for early empirical therapy of IA has become increasingly apparent since centers which practice this approach have reported lower mortality rates (2, 5) .
Techniques to detect specific anti-Aspergillus antibodies have demonstrated poor sensitivity (32) , so that increasing attention has focused on antigen detection tests. This approach has been used successfully in other opportunistic mycoses, notably cryptococcosis (18) . Previously, Aspergillus antigen has been demonstrated in serum, urine, and bronchoalveolar lavage fluid samples from both infected humans (9, 10, 23, 25, 26, 28, 31 ; K. A. Haynes and T. R. Rogers, Program Abstr. 29th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 1146, 1989) and experimental animals (1, 8, 14, 15, 19, 21, 24, 27, 29) . However, with the exception of galactomannan (GM), the antigens used in these assays, and as a consequence the antigens that are circulating or excreted during IA, have not been identified or characterized.
We examined serial urine samples from patients who were documented as having IA with the aim of identifying immunodominant Aspergillus antigens that could be used in a rapid diagnostic assay.
MATERIALS AND METHODS
Patients and specimen collection. We collected serial urine samples from 10 patients with histologically and/or microbiologically proven IA. In eight patients (Ul to U6, U8, and U9), the diagnosis of IA was confirmed by histological demonstration of septate branched hyphae in, and culture of Aspergillus spp. from, deep tissue specimens obtained postmortem. In the remaining two (U7 and U10), diagnosis was * Corresponding author. based on the following criteria: (i) fever (>38°C) for >5 days unresponsive to systemic antibacterial antibiotics, and (ii) repeated isolation of the same Aspergillus sp. from sputum and/or bronchoalveolar lavage fluids in the presence of pulmonary infiltrates.
The causative organism of IA in seven cases (U2 to U4 and U6 to U9) was Aspergillus fumigatus, and in one case each it was A. flavus (Ul) and mixed A. fumigatus-A. flavus (U10); whereas in the last patient (U5) a fungus from the A. glaucus group was isolated.
Eight patients had undergone bone marrow transplantation for leukemia (five patients), congenital immunodeficiency (one), or inborn errors of metabolism (two); the remaining two patients received remission induction therapy for leukemia.
The mean age of the patients was 18.3 years (range, 1.6 to 63), and they were all neutropenic at the onset of IA.
In addition, urine samples from 23 neutropenic patients who showed no evidence of fungal infection were collected and pooled. Of these patients, 12 had hematological malignancies and 11 had inborn errors of metabolism. Seventeen underwent bone marrow transplantation, and the remaining six received remission induction therapy for their leukemia. At the time of collection, four patients had positive blood cultures containing coagulase-negative staphylococci.
Urine samples were filtered (0.5-,um-pore-size filter; Flow Laboratories, Rickmansworth, United Kingdom), dialyzed overnight at 4°C against distilled water, and concentrated 10-fold under a vacuum in a Rotavapor (Technik AG, Flawil, Switzerland). Concentrated urine samples were centrifuged at 13,500 X g for 20 min, and the supernatants were stored at -70°C until analyzed.
Antigen preparations. A water-soluble (WS) antigen fraction of A. fumigatus was prepared as described by Wilson and Hearn (30) . Briefly, 106 conidia of A. fumigatus NCPF 2109 (Mycological Reference Laboratory, National Collection of Pathogenic Fungi, Colindale, London, United Kingdom) were inoculated into 300 ml of a 2% (wt/vol) glucose-1% (wt/vol) peptone liquid medium in a 2-liter Erlenmeyer flask and cultured for 3 days with constant aeration at 37°C. This starter culture was transferred to 3 liters of the same medium in a 5-liter Erlenmeyer flask and incubated for 4 more days under identical conditions. The mycelial mat was separated from the culture filtrate (CF) by filtration through Whatman no. 1 filter paper (Whatman, Maidstone, United Kingdom) and washed with at least 3 liters of sterile distilled water.
The washed mycelial mat was homogenized in a kitchen blender in 0.4% (wt/vol) NH4HCO3 (pH 7.3). The resultant slurry was mixed 2:1 with 0.1-mm (diameter) glass beads in a Vi-4 cell disintegrator (Edmund Buhler AG, Tubingen, Federal Republic of Germany) and disrupted until more than 80% cell breakage had occurred. Mycelial breakage was checked by light microscopy.
The mycelial extract was separated from the glass beads on a sintered glass funnel and centrifuged at 12,000 x g for 30 min to remove cell debris. The supernatant was filtered (0.1-,um-pore-size filter; Flow), dialyzed extensively against distilled water, and then lyophilized. This extract was designated the WS extract.
In addition, a CF antigen from a 2-day fermenter culture of A. fumigatus was prepared. Fresh conidia (106) were inoculated into 50 ml of Sabouraud liquid medium in a 150-ml flask and incubated at 25°C for 3 days, with stirring at 100 rpm.
This was added to 1.4 liters of the same medium in a 2-liter fermenter (Bio-Lafitte, Poissy, France) and cultured for 2 days at 25°C with an air supply of 0.5 liters/min and stirring at 600 rpm. This starter culture was used to seed 20 liters of Sabouraud liquid medium in a fermenter (Chemap, Zurich, Switzerland). This culture was incubated as above for 42 to 45 h. The CF was separated from the mycelium by filtration, dialyzed extensively against distilled water, and lyophilized. This extract was designated CF.
Antisera and monoclonal antibody. Rabbit antiserum (anti-CW) prepared against a cell wall extract of A. fumigatus NCPF 2109 (11) was a kind gift from V. M. Hearn (Mycological Reference Laboratory).
Rat immunoglobulin G (IgG) monoclonal antibody (EBA1) to A. fumigatus GM was a kind gift from D. Stynen, Eco-Bio nV, Genk, Belgium. This antibody was specific for the GM component of all species of Aspergillus tested, including A. Anti-CW was diluted 1:10 in phosphate-buffered saline (PBS) and incubated with the ligated gel overnight at 4°C. After completion of binding, the gel was placed into a disposable column (Bio-Rad Laboratories, Watford, United Kingdom) and the nonbound fraction (nonbound anti-CW) was eluted with PBS. This was dialyzed extensively against distilled water and then concentrated back to its original volume.
Electrophoresis and immunoblotting. In some experiments, 125I-protein A and 1251I-anti-rabbit
IgG were used instead of horseradish peroxidase-conjugated antibodies and bands were revealed by exposure on X-ray film.
RESULTS
When the urine samples from IA patients (Ul to U10)
were probed with anti-CW, seven antigens were detected with apparent molecular masses of 44, 38, 29, 18, 14, 13, and 11 kDa (Fig. 1, lanes lb to lOb) anti-CW (Fig. 1, lane A; Fig. 2 , lane la). In addition, as absorption of the anti-CW with the 48-h CF extract led to a reduction in binding, the urinary antigens were probably produced early in the growth of the fungus. None of the seven antigen bands could be detected with preimmunization serum, but weak nonspecific staining was seen at 100, 67, 59, and 23 kDa (Fig. 1, lanes la to 10a) .
Sufficient urine was available from three patients (U5, U7, and U10) to allow probing with the EBAl monoclonal antibody to A. fumigatus GM. A totally different band pattern was seen with this antibody when compared with anti-CW (Fig. 3, lanes 2 to 4) . Staining was weaker, and bands were more diffuse. Most of the staining occurred at molecular masses greater than 45 kDa (Fig. 3, lanes 1 to 4) . However, two urine samples (U5 and U10) showed in each case a weak band at approximately 21 kDa (Fig. 3, lanes 2  and 4) . None of the antigens revealed with anti-CW could be demonstrated when the urine samples were probed with EBA1, confirming that they do not contain GM. Pooled urine from the 23 neutropenic patients without evidence of aspergillosis showed the same staining patterns when incubated with either anti-CW or preimmunization serum. Diffuse, lightly stained bands were seen at approximately 50, 40, 25, and 16 kDa. EBAl did not stain any component of these urine samples (Fig. 3, lane 5) . DISCUSSION Most of the methods described to detect circulating Aspergillus antigens during IA have employed ill-defined reagents. For example, the concanavalin A-binding fractions often used in enzyme-linked immunosorbent assays (15, 31) have been shown to be complex mixtures comprising at least 14 components (30); a positive test result could therefore indicate the presence of any one of these molecules. Currently, the only defined antigen known to circulate during IA is GM (9, 14, 27; Haynes and Rogers, 29th ICAAC). GM has been characterized chemically (3, 4) (14) ; it was suggested that this increased size was due to complexing of the polysaccharide to protein in vivo (21) . We found that the majority of GM-containing antigens migrate with an apparent molecular mass of greater than 45 kDa (Fig. 3, lanes 1 to  4) . The diffuse staining seen in these blots is characteristic of a highly glycosylated moiety.
By using an experimental animal model of IA infection, De Repentigny et al. (8) found circulating antigenic components that did not bind to concanavalin A but could inhibit binding of anti-Aspergillus antibody in their enzyme-linked immunosorbent inhibition assay; this suggests that non-GM antigens were present. Similarly, we used an inhibition enzymelinked immunosorbent assay methodology, incorporating either a monoclonal antibody to A. fumigatus GM or a polyvalent high-titer human anti-Aspergillus serum, and found 11% of specimens from patients with IA in which antigen could only be detected in the polyclonal assay (Haynes and Rogers, 29th ICAAC). Our present study confirms these observations and reveals the non-GM antigens that are present during IA.
Phillips and Radigan (19) have also demonstrated the presence of several Aspergillus antigens in the sera of rabbits experimentally infected with A. fumigatus; the major protein had an apparent molecular mass of 80 kDa. We were unable to detect a band at this molecular mass in the urine samples of humans with IA. Our preliminary experiments with sera (data not shown) from IA and noninfected subjects were not successful, due to a high degree of nonspecific binding of the anti-CW rabbit antiserum to components in human sera.
The antigens described here were found in urine samples from patients with IA caused by species of Aspergillus other than A. fumigatus (Ul, U5, and U10). This finding is not surprising, as much work has shown that different species share certain antigenic determinants (3, 4, 11, 30) . In addition, the WS antigen fraction used here contains common antigens, as shown by both enzyme-linked immunosorbent assay and immunoblotting, when prepared from either A. fumigatus NCPF 2109 or A. flavus NCPF 2008 (unpublished results).
Our results show that both GM and non-GM antigens are present during IA. This pattern is repeated in other fungal infections in which both polysaccharide (6) and protein (20) antigens can be demonstrated in body fluids. For example, in systemic candidiasis it has been shown that both mannancontaining glycoprotein (12) and a 47-or 48-kDa protein (16) antigens are circulating.
In this study, we identified at least seven non-GM antigens that are present during IA. The purification and characterization of these non-GM antigens should lead to the development of more sensitive reagents which would allow the rapid detection of Aspergillus infection and which may be used to predict the development of invasive disease.
